PhytoHealth Corporation (4108.TW)

TWD 14.35

(7.49%)

Operating Expenses Summary of PhytoHealth Corporation

  • PhytoHealth Corporation's latest annual operating expenses in 2023 was 67.64 Million TWD , down -11.43% from previous year.
  • PhytoHealth Corporation's latest quarterly operating expenses in 2024 Q2 was 46.19 Million TWD , down -8.33% from previous quarter.
  • PhytoHealth Corporation reported a annual operating expenses of 213.74 Million TWD in annual operating expenses 2022, up 1.53% from previous year.
  • PhytoHealth Corporation reported a annual operating expenses of 210.52 Million TWD in annual operating expenses 2021, down -2.47% from previous year.
  • PhytoHealth Corporation reported a quarterly operating expenses of 46.19 Million TWD for 2024 Q2, down -8.33% from previous quarter.
  • PhytoHealth Corporation reported a quarterly operating expenses of 69.89 Million TWD for 2024 Q3, down -66.26% from previous quarter.

Annual Operating Expenses Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Operating Expenses of PhytoHealth Corporation (2023 - 2009)

Year Operating Expenses Operating Expenses Growth
2023 67.64 Million TWD -11.43%
2022 213.74 Million TWD 1.53%
2021 210.52 Million TWD -2.47%
2020 215.84 Million TWD -27.92%
2019 299.42 Million TWD -7.56%
2018 323.9 Million TWD 10.71%
2017 292.56 Million TWD 16.23%
2016 251.72 Million TWD -6.48%
2015 269.15 Million TWD -22.56%
2014 347.54 Million TWD 45.44%
2013 238.96 Million TWD 55.64%
2012 153.53 Million TWD -24.78%
2011 204.11 Million TWD -10.47%
2010 227.96 Million TWD -10.73%
2009 255.38 Million TWD 0.0%

Peer Operating Expenses Comparison of PhytoHealth Corporation

Name Operating Expenses Operating Expenses Difference
Grape King Bio Ltd 6.03 Billion TWD 98.88%
Standard Chem & Pharm CO., LTD. 1.46 Billion TWD 95.385%
Maywufa Company Ltd. 854.37 Million TWD 92.083%
ScinoPharm Taiwan, Ltd. 901.49 Million TWD 92.497%
Lotus Pharmaceutical Co., Ltd. 4.48 Billion TWD 98.49%
LIWANLI Innovation Co., Ltd. 54.86 Million TWD -23.288%
YungShin Global Holding Corporation 2.04 Billion TWD 96.697%
SCI Pharmtech, Inc. 190.02 Million TWD 64.403%
Formosa Laboratories, Inc. 1.24 Billion TWD 94.581%
PharmaEssentia Corporation 4.49 Billion TWD 98.495%
Bora Pharmaceuticals Co., LTD. 1.74 Billion TWD 96.117%